Active-ingredient Dossier
Levodopa
Active-ingredient Dossier for Levodopa (dopamine precursor). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: LECTEVA
- Brand: SINEMET
- Brand: SINADOPA
- Brand: Carbidopa
- Brand: APO-LEVODOPA/CARBIDOPA
- Brand: CARLEVENT
- Therapeutic area: Neurology
What is
Levodopa Levodopa is a dopamine precursor.
Australian brands containing
Levodopa — LECIGON — Carbidopa — CARLEVENT — KINSON — STALEVO — Levodopa — LEVODOPA/CARBIDOPA — LEVODOPA/CARBIDOPA-WGR — ORIDOPA — ORIDOPA
Therapeutic areas
Levodopa is registered in neurology, with ten brands containing this ingredient on the ARTG.
Sponsor landscape
Levodopa is marketed by seven sponsors: Alphapharm, Arrotex Pharmaceuticals, Mayne Pharma, Stada Pharmaceuticals, GM Pharma, and Orion Pharma (AUS).
PBS and regulatory activity
No brands containing levodopa are currently PBS-listed. In the 2019–20 fiscal year, government expenditure on levodopa products reached approximately 63 million dollars across 266,088 scripts. Two brands have PBAC outcomes on record, with the latest outcome dated 1 November 2024. No AusPARs are on record for levodopa.